PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.52%
Revenue growth at 50-75% of 6203.T's 33.82%. Martin Whitman would worry about competitiveness or product relevance.
3.07%
Gross profit growth under 50% of 6203.T's 27.05%. Michael Burry would be concerned about a severe competitive disadvantage.
-23.79%
Negative EBIT growth while 6203.T is at 160.81%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-11.85%
Negative operating income growth while 6203.T is at 133.78%. Joel Greenblatt would press for urgent turnaround measures.
-39.97%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-40.07%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-40.07%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.94%
Positive 10Y revenue/share CAGR while 6203.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
70.25%
5Y revenue/share CAGR above 1.5x 6203.T's 8.51%. David Dodd would look for consistent product or market expansions fueling outperformance.
51.85%
3Y revenue/share CAGR above 1.5x 6203.T's 5.02%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-87.55%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-95.82%
Negative 5Y net income/share CAGR while 6203.T is 227.17%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
109.89%
3Y net income/share CAGR above 1.5x 6203.T's 12.41%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
284.19%
10Y equity/share CAGR above 1.5x 6203.T's 42.23%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
35.04%
5Y equity/share CAGR above 1.5x 6203.T's 18.01%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
26.04%
3Y equity/share CAGR above 1.5x 6203.T's 15.21%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.25%
Our AR growth while 6203.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
7.64%
We show growth while 6203.T is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.58%
Positive asset growth while 6203.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.22%
We have a declining book value while 6203.T shows 0.74%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
4.58%
Debt shrinking faster vs. 6203.T's 11.20%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
1.28%
R&D dropping or stable vs. 6203.T's 163.64%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-17.74%
We cut SG&A while 6203.T invests at 8.20%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.